Glaukos Corporation
Symbol: GKOS (NYSE)
Company Description:
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.
- Today's Open: $84.56
- Today's High: $87.318
- Today's Low: $84.065
- Today's Volume: 220.04K
- Yesterday Close: $84.49
- Yesterday High: $85.12
- Yesterday Low: $83
- Yesterday Volume: 817.73K
- Last Min Volume: 3.42K
- Last Min High: $87.226
- Last Min Low: $87.09
- Last Min VWAP: $87.11908
- Name: Glaukos Corporation
- Website: https://www.glaukos.com
- Listed Date: 2015-06-25
- Location: ALISO VIEJO, CA
- Market Status: Active
- CIK Number: 0001192448
- SIC Code: 3841
- SIC description: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
- Market Cap: $4.85B
- Round Lot: 100
- Outstanding Shares: 57.35M
- Asset Type: CS
Filing Date | Filing Type | Format |
---|---|---|
2025-09-24 | 4 | View |
2025-09-24 | 4 | View |
2025-09-24 | 4 | View |
2025-09-22 | 4 | View |
2025-09-22 | 4 | View |
2025-09-22 | 4 | View |
2025-09-22 | 144 | View |
2025-09-12 | 4 | View |
2025-09-11 | 144 | View |
2025-08-20 | S-8 | View |
2025-08-12 | SCHEDULE 13G | View |
2025-08-12 | 8-K | View |
2025-08-07 | SCHEDULE 13G/A | View |
2025-08-04 | 10-Q | View |
2025-07-30 | 8-K | View |
2025-06-13 | 4 | View |
2025-06-03 | 8-K | View |
2025-06-02 | 4 | View |
2025-06-02 | 4 | View |
2025-06-02 | 4 | View |